MedTrace Logo

Study to Improve the Treatment of Epilepsy (SITE)

NCT00133081 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 255

Last updated 2005-10-21

No results posted yet for this study

Summary

The purpose of this study is to assess whether changing antiepileptic medication can reduce side effects and improve the quality of life in patients with epileptic seizures that are well controlled with antiepileptic drugs.

Conditions

Interventions

DRUG

All registered antiepileptic drugs

Sponsors & Collaborators

Principal Investigators

  • Cees A van Donselaar, MD PhD · UMC Utrecht

  • Sabine G Uijl, MSc · UMC Utrecht

  • Albert P Aldenkamp, PhD · AZM Maastricht

  • Cuno SP Uiterwaal, PhD · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2006-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00133081 on ClinicalTrials.gov